FUN26 Antibody

What is the FUN26 protein and why would researchers need antibodies against it?

FUN26 (Function Unknown Now 26) is a nucleoside transporter expressed in yeast vacuoles that functions as an Equilibrative Nucleoside Transporter (ENT). It demonstrates broad selectivity for both nucleoside and nucleobase substrates with high affinity . Antibodies against FUN26 are essential tools for researchers investigating membrane transport mechanisms, particularly in studying protein expression, localization, and purification verification. As the only putative ENT family member in S. cerevisiae, FUN26 serves as an important model system for understanding fundamental nucleoside transport mechanisms.

What experimental systems are used to characterize FUN26 that would benefit from antibody applications?

The primary experimental system for characterizing FUN26 involves reconstituting the purified protein in proteoliposomes (PLs). This system allows for detailed functional analysis in a defined lipid environment. Anti-FUN26 antibodies would be valuable for Western blot verification of protein insertion into PLs, immunohistochemical localization studies, and quality control during purification processes . The paper demonstrates that FUN26 can be expressed as an NH₂-terminal 10-histidine fusion construct in W303 yeast using an episomal galactose-inducible system, then extracted and purified using detergent solubilization, making this an ideal system where antibodies would enhance experimental verification.

What expression systems are most suitable for producing FUN26 protein for antibody generation?

Based on successful experimental approaches, the optimal expression system for FUN26 is S. cerevisiae strain W303-Δpep4 with an episomal galactose-inducible system . This system allows for expression of FUN26 as an NH₂-terminal 10-histidine fusion construct. The protein can be extracted from total cell membrane pellets following DDM (n-dodecyl β-D-maltoside) solubilization and purified to homogeneity. The expression construct utilizes the "83χ" plasmid with homologous recombination in yeast, resulting in significant protein yields of approximately 150 μg of purified protein per liter of yeast culture , which would provide sufficient material for antibody generation.

How should researchers validate the specificity of FUN26 antibodies?

To validate FUN26 antibody specificity, researchers should implement a multi-step validation protocol:

• Comparative Western blotting - Test antibody reactivity against wild-type FUN26 versus FUN26-deficient control samples

• Recombinant protein controls - Verify recognition of purified FUN26 protein

• Mutant analysis - Use FUN26 mutants (such as G463A and G216A) as controls

• Competition assays - Pre-incubate antibody with purified FUN26 protein to demonstrate specific blocking

The paper demonstrates that anti-His antibodies successfully detected FUN26 in Western blots, suggesting that similar approaches would work for FUN26-specific antibodies . Additionally, testing against FUN26 mutants described in the research (G463A, G216A, L390A, and F249I) would provide excellent controls for antibody specificity validation.

What protocols work best for immunodetection of FUN26 in membrane fractions?

For optimal immunodetection of FUN26 in membrane fractions, researchers should consider:

• Sample preparation: Extract total cell membranes using a French pressure cell at 20,000 psi followed by differential centrifugation

• Membrane solubilization: Use 2 mM DDM in a buffer containing 50 mM KH₂PO₄ at pH 7.4, 50 mM NaCl, 1 mM MgCl₂, 1 mM PMSF, and 5 mM β-mercaptoethanol

• SDS-PAGE conditions: Use standard protocols with attention to proper denaturation of membrane proteins

• Transfer conditions: Optimize transfer parameters for hydrophobic membrane proteins

• Blocking solution: Use 5% non-fat dry milk in TBST buffer

The research demonstrated successful detection of the purified FUN26 using an anti-His antibody (Qiagen, catalog no. 35370), suggesting these conditions would be compatible with FUN26-specific antibodies as well .

How can antibodies be used to study FUN26 mutants and their functional impacts?

Antibodies are invaluable tools for studying FUN26 mutants and their functional impacts through multiple approaches:

• Quantification of expression levels: Compare wild-type FUN26 with mutants like G463A (transport deficient) and G216A (expression deficient)

• Subcellular localization studies: Determine if mutations affect protein targeting to vacuolar membranes

• Conformation-specific antibodies: Develop antibodies that recognize specific conformational states of the transporter

• Pull-down assays: Identify potential binding partners affected by mutations

Research showed that the G463A mutant expressed at levels similar to native FUN26 but lacked transport function, while the G216A mutant showed severe attenuation of expression . Antibodies would help quantify these differences precisely and provide insights into mechanistic details of how these mutations affect protein function.

What approaches can be used with antibodies to study the relationship between FUN26 structure and transport function?

The research demonstrated that FUN26 has unique substrate transport profiles relative to other ENT family members, with specific residues (G463, G216, F249, L390) playing crucial roles in transport function . Antibodies targeting these regions would provide valuable insights into structure-function relationships.

How can FUN26 antibodies facilitate studies of substrate specificity?

FUN26 antibodies can enhance substrate specificity studies through:

• Co-immunoprecipitation with substrate analogs: Use antibodies to pull down FUN26 complexed with various substrates

• Conformational change detection: Develop antibodies that detect transport-associated conformational changes

• Domain-specific blocking: Use antibodies that target substrate binding domains to analyze competitive inhibition

• Mutagenesis validation: Verify expression levels of mutants designed to alter substrate specificity

The research showed that FUN26 transports a broad range of purine and pyrimidine nucleosides and nucleobases but is sensitive to C(2')-ribose and C(5')-ribose modifications . FUN26 does not transport [³H]UTP, [³H]C(2')-deoxyuridine, [³H]gemcitabine, [³H]cytarabine, or [³H]adenosine, but does transport [³H]uridine, [³H]cytidine, [³H]uracil, [³H]cytosine, [³H]thymidine, [³H]guanosine, [³H]inosine, [³H]adenine, and [³H]hypoxanthine . Antibodies would help elucidate the structural basis for these specificities.

What are the main challenges in generating antibodies against integral membrane proteins like FUN26?

Generating antibodies against membrane proteins like FUN26 presents several challenges:

• Limited antigenicity of transmembrane domains: The hydrophobic regions buried in the membrane are poorly accessible to the immune system

• Protein denaturation during purification: Maintaining native conformation during antibody production is difficult

• Low expression yields: The paper notes that FUN26 yields approximately 150 μg of purified protein per liter of yeast culture

• Conformational variability: The research suggests FUN26 may exhibit "conformational malleability," potentially resulting in a subpopulation of non-functional protein

To overcome these challenges, researchers should consider using purified FUN26 reconstituted in nanodiscs or detergent micelles, or generating antibodies against hydrophilic loops and N/C-terminal domains that are more accessible.

How can researchers optimize immunoprecipitation protocols for FUN26?

For optimal immunoprecipitation of FUN26:

• Detergent selection: Use 2 mM DDM for membrane solubilization, as demonstrated effective for FUN26 extraction

• Buffer composition: Utilize 50 mM KH₂PO₄ at pH 7.4, 50 mM NaCl, 1 mM MgCl₂, 1 mM PMSF, and 5 mM β-mercaptoethanol

• Temperature control: Maintain samples at 4°C throughout the procedure, as FUN26 is stable at this temperature

• Crosslinking consideration: Consider mild crosslinking to stabilize protein-protein interactions

• Antibody coupling: Use covalent coupling to beads to prevent antibody contamination in eluates

The research demonstrates that FUN26 is stable in dilute form at 4°C and can withstand pH changes between 5.5 and 8.2, as well as monovalent cation concentrations between 0 and 300 mM NaCl , providing flexibility in immunoprecipitation buffer conditions.

How might antibodies help elucidate the evolutionary relationships between FUN26 and human ENTs?

Antibodies can facilitate evolutionary studies between FUN26 and human ENTs through:

• Epitope conservation analysis: Develop antibodies against conserved regions to test cross-reactivity

• Structural comparisons: Use antibodies to probe similar functional domains across species

• Functional conservation studies: Employ antibodies to detect conformational similarities during transport

The research highlights that FUN26 shares similar predicted membrane topology with hENT3, and both proteins are expressed in intracellular membranes . Specifically, the Gly-463 residue in FUN26 corresponds to the conserved Gly-427 in hENT3 and Gly-408 in hENT1-2, which are critical for transport activity . Antibodies targeting these conserved regions would help elucidate evolutionary relationships.

What role could FUN26 antibodies play in understanding vacuolar transport mechanisms?

FUN26 antibodies would be instrumental in understanding vacuolar transport mechanisms through:

• Co-localization studies: Determine relationship with other vacuolar transporters

• Regulated expression analysis: Study how environmental conditions affect FUN26 localization and expression

• Trafficking pathways: Investigate how FUN26 is targeted to vacuolar membranes

The research confirms that FUN26 is expressed in vacuole membranes , but detailed studies of its regulation, trafficking, and integration with other vacuolar functions would benefit significantly from specific antibodies for immunolocalization and quantitative expression analysis.